Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadera J Sweiss

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Heart Failure|August 4, 2011
Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational studyAmit R Patel, Michael R Klein, Sonal Chandra, et al.
Respiratory Medicine Case Reports|November 7, 2022
Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature reviewJaleel Jerry G Sweis, Nabil William G Sweis, Christian Ascoli, et al.
Annals of the American Thoracic Society|September 24, 2020
Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire in a Multicenter Prospective StudyRobert P Baughman, Marc A Judson, Jennifer L Beaumont, et al.
Chest|November 10, 2022
Efzofitimod for the Treatment of Pulmonary SarcoidosisDaniel A Culver, Shambhu Aryal, Joseph Barney, et al.
Circulation. Cardiovascular Imaging|January 15, 2016
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic ResonanceGillian Murtagh, Luke J Laffin, John F Beshai, et al.
Respiratory Medicine|March 31, 2022
The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP)Marc A Judson, Recai Yucel, Sara Preston, et al.
Echocardiography (Mount Kisco, N.Y.)|September 29, 2016
Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fractionGillian Murtagh, Luke J Laffin, Kershaw V Patel, et al.
ERJ Open Research|January 5, 2023
Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosisChristen L Vagts, Yi-Shin Chang, Christian Ascoli, et al.
Annals of the American Thoracic Society|July 21, 2015
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis ProtocolDavid R Moller, Laura L Koth, Lisa A Maier, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialMarco Matucci-Cerinic, Christopher P Denton, Daniel E Furst, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Heart Failure|August 4, 2011
Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational studyAmit R Patel, Michael R Klein, Sonal Chandra, et al.
Respiratory Medicine Case Reports|November 7, 2022
Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature reviewJaleel Jerry G Sweis, Nabil William G Sweis, Christian Ascoli, et al.
Annals of the American Thoracic Society|September 24, 2020
Evaluating the Minimal Clinically Important Difference of the King's Sarcoidosis Questionnaire in a Multicenter Prospective StudyRobert P Baughman, Marc A Judson, Jennifer L Beaumont, et al.
Chest|November 10, 2022
Efzofitimod for the Treatment of Pulmonary SarcoidosisDaniel A Culver, Shambhu Aryal, Joseph Barney, et al.
Circulation. Cardiovascular Imaging|January 15, 2016
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic ResonanceGillian Murtagh, Luke J Laffin, John F Beshai, et al.
Respiratory Medicine|March 31, 2022
The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: Results from the On-line Sarcoidosis Assessment Platform Study (OSAP)Marc A Judson, Recai Yucel, Sara Preston, et al.
Echocardiography (Mount Kisco, N.Y.)|September 29, 2016
Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fractionGillian Murtagh, Luke J Laffin, Kershaw V Patel, et al.
ERJ Open Research|January 5, 2023
Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosisChristen L Vagts, Yi-Shin Chang, Christian Ascoli, et al.
Annals of the American Thoracic Society|July 21, 2015
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis ProtocolDavid R Moller, Laura L Koth, Lisa A Maier, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialMarco Matucci-Cerinic, Christopher P Denton, Daniel E Furst, et al.
Pageof 8